Shares of Alkem Laboratories were in focus after the company disclosed that it has received a demand order from the Additional Commissioner, Central Goods and Services Tax, Goa, under the Goods and Services Tax Act, 2017.
In a regulatory filing dated January 22, 2026, Alkem Laboratories informed stock exchanges that the order has been issued for its Goa GSTIN for the period from FY2019–20 to FY2022–23. The statutory authority has raised a GST demand of Rs 2.34 crore, along with applicable interest and a penalty of an equal amount of Rs 2.34 crore, under the provisions of the IGST Act, 2017, CGST Act, 2017 and SGST Act, 2017.
According to the disclosure, the demand order primarily alleges excess availment of Input Tax Credit. The company stated that it does not agree with the order and is in the process of taking appropriate actions, including filing an appeal against the demand.
Alkem Laboratories further clarified that the order was received on January 21, 2026. The company also stated that there is no material impact on its financial position, operations or other business activities arising from the order at this stage.
The information has been disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and has also been made available on the company’s website.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
